The factor Xa inhibitor failed to demonstrate noninferiority to warfarin in preventing valve thrombosis or thromboembolism in conjunction with the bileaflet On-X mechanical valve.
Is It Time to Redefine ‘Low Risk’ Surgical Aortic Valve Replacement?
Operative outcomes of SAVR patients with a PROM score < 4% have improved over time while expected risk estimates remained flat, a large Cleveland Clinic study shows.
When to Refer for SAVR in an Era of Expanding TAVR Use?
The choice between surgical and transcatheter aortic valve replacement must account for individualized clinical and anatomic factors and lifetime management considerations, concludes a new expert review.
5-Year COMMENCE Data Show Continued Promise for Novel Valve Tissue in SAVR
Through five years of follow-up, no cases of valve thrombosis or structural valve deterioration were observed with a bioprosthesis using the new Resilia tissue technology.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
CMS Should Consider Quality, Not Just Quantity, for TAVR Coverage
Our experts outline their vision of ideal changes to the National Coverage Determination for programs performing transcatheter aortic valve replacement. A CMS decision is due in June 2019.
Surgical Vs. Transcatheter Aortic Valve Replacement: Watch the Right Ventricle
The latest PARTNER 2A analysis finds that worsening RV function is much more common after SAVR than TAVR. And it predicts greater risk for poor outcomes regardless of procedure type.
Worsened Outcomes Due to Prior Chest Radiation Extend to SAVR for Aortic Stenosis
Long-term survival after surgical aortic valve replacement is lower when it’s for aortic stenosis that’s due to prior chest radiotherapy, a new study shows. But it’s too soon to assume TAVR is a panacea.
New PARTNER 2A Insights: Worsened RV Function and Tricuspid Regurgitation More Common with SAVR Vs. TAVR
The transcatheter approach to aortic valve replacement in intermediate-risk patients appears to curb the risk of these potentially deadly effects, new subanalyses presented at ACC.17 show.
Aortic Valve Surgery for Chronic Severe Regurgitation: Earlier May Be Better
Surgery at a high-volume center boosts long-term survival, even in patients with minimal or no symptoms and preserved LVEF. So finds a large new analysis with implications for treatment guidelines.
SAVR Outcomes Improve Even as Population Ages
As 77 million baby boomers retire, the numbers of patients seeking treatment for aortic valve disease will increase – and Cleveland Clinic has the vast experience necessary to perform complex valve surgery